These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34743917)

  • 1. Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D
    Sigvard AK; Nielsen MØ; Gjedde A; Bojesen KB; Fuglø D; Tangmose K; Kumakura Y; Heltø K; Ebdrup BH; Jensen LT; Rostrup E; Glenthøj BY
    Biol Psychiatry; 2022 Jan; 91(2):236-245. PubMed ID: 34743917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder.
    Wong SMY; Suen YN; Wong CWC; Chan SKW; Hui CLM; Chang WC; Lee EHM; Cheng CPW; Ho GCL; Lo GG; Leung EYL; Yeung PKMA; Chen S; Honer WG; Mak HKF; Sham PC; McKenna PJ; Pomarol-Clotet E; Veronese M; Howes OD; Chen EYH
    Psychopharmacology (Berl); 2022 Jul; 239(7):2133-2141. PubMed ID: 35211769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of treatment response in first-episode psychosis: an
    Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
    Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
    Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
    JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [
    Kim S; Shin SH; Santangelo B; Veronese M; Kang SK; Lee JS; Cheon GJ; Lee W; Kwon JS; Howes OD; Kim E
    Mol Psychiatry; 2021 Jul; 26(7):3476-3488. PubMed ID: 32929214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders.
    Cheng PWC; Chang WC; Lo GG; Chan KWS; Lee HME; Hui LMC; Suen YN; Leung YLE; Au Yeung KMP; Chen S; Mak KFH; Sham PC; Santangelo B; Veronese M; Ho CL; Chen YHE; Howes OD
    Neuropsychopharmacology; 2020 Oct; 45(11):1870-1876. PubMed ID: 32612207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment.
    Jauhar S; McCutcheon RA; Veronese M; Borgan F; Nour M; Rogdaki M; Pepper F; Stone JM; Egerton A; Vamvakas G; Turkheimer F; McGuire PK; Howes OD
    Transl Psychiatry; 2023 May; 13(1):184. PubMed ID: 37253720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine partial agonists: a new class of antipsychotic.
    Lieberman JA
    CNS Drugs; 2004; 18(4):251-67. PubMed ID: 15015905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
    Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):579-88. PubMed ID: 26016467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.
    Ito H; Takano H; Arakawa R; Takahashi H; Kodaka F; Takahata K; Nogami T; Suzuki M; Suhara T
    PLoS One; 2012; 7(9):e46488. PubMed ID: 23029533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
    Brown ES; Jeffress J; Liggin JD; Garza M; Beard L
    J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
    Eisenberg DP; Yankowitz L; Ianni AM; Rubinstein DY; Kohn PD; Hegarty CE; Gregory MD; Apud JA; Berman KF
    Neuropsychopharmacology; 2017 Oct; 42(11):2232-2241. PubMed ID: 28387222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The next generation of "atypical" antipsychotics: the role of positron emission tomography].
    Gründer G; Wong DF
    Fortschr Neurol Psychiatr; 2003 Aug; 71(8):415-20. PubMed ID: 12910447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Reeves S; McLachlan E; Bertrand J; D'Antonio F; Brownings S; Nair A; Greaves S; Smith A; Taylor D; Dunn J; Marsden P; Kessler R; Howard R
    Brain; 2017 Apr; 140(4):1117-1127. PubMed ID: 28334978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S
    Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.